Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes

Objective: We recently observed a greater increase in plasma levels of bioactive glucose-dependent insulinotropic polypeptide (GIP) than glucagon-like peptide 1 (GLP-1) using the receptor-mediated bioassays in the subjects with normal glycemic tolerance (NGT) treated with dipeptidyl peptidase 4 (DPP...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Tsuyoshi Yanagimachi, Yukihiro Fujita, Yasutaka Takeda, Jun Honjo, Hiroki Yokoyama, Masakazu Haneda
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2020-04-01
סדרה:	Frontiers in Endocrinology
נושאים:	glucose-dependent insulinotropic polypeptide glucagon-like peptide 1 glucagon receptor-mediated bioassay dipeptidyl peptidase 4
גישה מקוונת:	https://www.frontiersin.org/article/10.3389/fendo.2020.00214/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!